The significance of vitamin D metabolism in human skin : An update;Zur Bedeutung des Vitamin-D-Stoffwechsels in der humanen Haut : Eine aktuelle Standortbestimmung

Hautarzt

Volumn 61, Issue 6, 2010, Pages 478-486

  Tremezaygues L ^a   Reichrath, J ^a  

^a SAARLAND UNIVERSITY   (Germany)

Author keywords

Antimicrobial peptides; Cancer prevention; Human skin; Skin cancer; Vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; 7 DEHYDROCHOLESTEROL; B7 ANTIGEN; CALCITRIOL; CD86 ANTIGEN; CHOLESTANETRIOL 26 MONOOXYGENASE; COLECALCIFEROL; GAMMA INTERFERON; KI 67 ANTIGEN; PARATHYROID HORMONE; POLYPEPTIDE ANTIBIOTIC AGENT; TUMOR NECROSIS FACTOR ALPHA; VITAMIN D; VITAMIN D DERIVATIVE; VITAMIN D RECEPTOR;

APOPTOSIS; BIOLOGICAL ACTIVITY; CD4+ CD25+ T LYMPHOCYTE; CELL DAMAGE; CELL PROLIFERATION; CELL PROTECTION; GENE EXPRESSION REGULATION; HORMONE ACTION; HUMAN; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; IMMUNOMODULATION; KERATINOCYTE; PHOTOAGING; PROTEIN INDUCTION; PSORIASIS; RADIATION EXPOSURE; REVIEW; SIGNAL TRANSDUCTION; SKIN PROTECTION; SUN EXPOSURE; ULTRAVIOLET B RADIATION; VITAMIN D DEFICIENCY; VITAMIN D METABOLISM; ANIMAL; CELL DIFFERENTIATION; CELL DIVISION; DNA REPAIR; IMMUNOCOMPETENCE; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; RADIATION INDUCED NEOPLASM; SKIN; SKIN TUMOR; SUNLIGHT;

ANIMALS; CALCITRIOL; CELL DIFFERENTIATION; CELL DIVISION; DNA REPAIR; HUMANS; IMMUNOCOMPETENCE; KERATINOCYTES; NEOPLASMS, RADIATION-INDUCED; SKIN; SKIN NEOPLASMS; SUNLIGHT; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 77954427153     PISSN: 00178470     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00105-009-1893-z     Document Type: Review

References (40)

1. Holick MF (2007) Vitamin D deficiency. NEJM 357:266-281
2. Hintzpeter B et al (2008) Vitamin D status and health correlates among German adults. Eur J Clin Nutr 62(9):1079-1089
3. Trémezaygues L (2009) In vitro Untersuchungen in humanen Keratinozyten über mögliche protektive Eigenschaften von 1,25-Dihydroxyvitamin D3 gegen UVB- und niedrigdosierte ionisierende Strahlung. Promotionsarbeit an der Universität des Saarlandes
4. 3 in an in vitro human skin equivalent model. J Invest Dermatol 117:1179-1185
5. Schlumpf M, Reichrath J, Lehmann B et al (in press) Fundamental questions to sun protection: a continuous education symposium at the University of Zürich on .,Vitamin D, immune system and sun protection". Dermatoendocrinol
6. 3 in human skin and the physiologic consequences. Science 210:203-205
7. Holick MF (2003) Evolution and function of Vitamin D. Recent Results Cancer Res 164:3-28
8. Lehmann B, Tiebel O, Meurer M (1999) Expression of vitamin D3 25-hydroxylase (CYP27) mRNA after induction by vitamin D3 or UVB radiation in keratinocytes of human skin equivalents-a preliminary study. Arch Dermatol Res 291:507-510
9. Seifert M, Tilgen W, Reichrath J (2009) Expression of vitamin D-1a-hydroxylase (1aOHase, CYP27B1) splicing variants in HaCaT keratinocytes and other skin cells: modulation by culture conditions and UV-B treatment in vitro. Anticancer Res 29(9):3659-3668
10. Reichrath J, Müller SM, Kerber A et al (1997) Biologic effects of topical calcipotriol (MC 903) treatment in psoriatic skin. J Am Acad Dermatol 36:1928
11. Reichrath J, Perez A, Chen TC et al (1997) The effectiveness of topical 1,25-dihydroxyvitamin D3 (1,25(OH)2D3) application in the treatment of psoriasis: an immunohistological evaluation. Acta Derm Venereol (Stockh) 77:268-272
12. 3 and its analogues for the treatment of psoriasis. In: Holick MF (Hrsg) Vitamin D: Physiology, molecular biologic and clinical aspects. The Humana Press Inc., Totowa New York, S 357-373
13. Reichrath J, Holick MF (n d) Psoriasis and other skin diseases. In: Feldman D, Glorieux FH, Pike JW (Hrsg) Vitamin D, 2nd edn. Academic, San Diego London Boston New York Sydney Tokyo Toronto
14. 3 as pluripo-tent immunomodulators. J Cell Biochem 88:223226
15. Homey B, Wang W, Soto H et al (2000) Cutting edge: The orphan chemokine receptor G protein-coupled receptor-2 (GPR-2, CCR10) binds the skin-associated chemokine CCL27 (CTACK/ALP/ILC). J Immunol 164:3465-3470
16. Gombard HF, Borregaard N, Koeffler HP (2005) Human cathelicidin antimicrobial peptide (CAMP) gene is a direct target of the vitamin D receptor and is strongly up-regulated in myeloid cells by 1,25-dihydroxyvitamin D3. FASEB J 19(9):1067-1077
17. Wang T-T, Nestel FP, Bourdeau V et al (2004) Cutting edge: 1,25-Dihydroxyvitamin D3 is a direct inducer of antimicrobial peptide gene expression. J Immunol 173(5):2909-2912
18. Weber G, Heilborn JD, Chamorro Jimenez CI et al (2005) Vitamin D induces the antimicrobial protein hCAP18 in human skin. J Invest Dermatol 124(5):1080-1082
19. Zanetti M (2004) Cathelicidins, multifunctional peptides of the innate immunity. J Leukoc Biol 75:39-48
20. Zaiou M, Nizet V, Gallo RL (2003) Antimicrobial and protease inhibitory functions of the human cathelicidin (hCAP18/LL-37) prosequence. J Invest Dermatol 120:810-816
21. Dorschner RA, Pestonjamasp VK, Tamakuwala S (2001) Cutaneous injury induces the release of cathelicidin anti-microbial peptides active against group A Streptococcus. J Invest Dermatol 117:9197
22. Frohm Nilsson M, Sandstedt B, Sorensen O et al (1999) The human cationic antimicrobial protein (hCAP18), a peptide antibiotic, is widely expressed in human squamous epithelia and colocalizes with interleukin-6. Infect Immun 67:2561-2566
23. Peric M, Koglin S, Dombrowski Y et al (2009) Vitamin D analogs differentially control antimicrobial peptide/"alarmin" expression in psoriasis. PLoS One 4(7):e6340
24. De Haes P, Garmyn M, Degreef H et al (2003) 1,25-dihydroxyvitamin D3 inhibits ultraviolet B induced apoptosis, jun kinase actiation and interleukin-6 production in primary human keratinocytes. J Cell Biochem 89:663-673
25. Lee JH, Youn JI (1998) The photoprotective effect of 1, 25-Dihydroxyvitamin D3 on ultraviolet B-in-duced damage in keratinocyte and its mechanisms of action. J Dermatol Sci 18:11-18
26. 3 is associated by an increase in p53 and a decrease in nitric oxide products. J Invest Dermatol 127:707-715
27. De Haes P, Garmyn M, Verstuyf A et al (2004) Two 14-epi analogues of 1, 25-dihydroxyvitamin D3 protect human keratinocytes against the effects of UVB. Arch Dermatol Res 295:527-534
28. De Haes P, Garmyn M, Verstuyf A et al (2005) 1, 25(OH)2D3 and analogues protect primary human keatinocytes against UVB-induced DNA damage. J Photochem Photobiol B 78(2):141-148
29. 3 protects human keratinocytes against UV-B-induced damage: in vitro analysis of cell viability/proliferation, DNA-damage and -repair. Dermatoendocrinol
30. 3 modulates effects of ionizing radiation (IR) on human keratinocytes: in vitro analysis of cell viability/proliferation, DNA-dama-ge and -repair. J Steroid Biochem Mol Biol (Epub ahead of print)
31. Osterlind A, Tucker MA, Stone BJ, Jensen OM (1988) The Danish case-control study of cutaneous malignant melanoma. II importance of UV-light exposure. Int J Cancer 42:319-324
32. Garland CF, Comstock GW, Garland FC et al (1989) Serum 25-hydroxyvitamin D and colon cancer: eight year prospective study. Lancet 2(8673):1176-1178
33. Grant WB (2002) An estimate of premature cancer mortality in the U.S. due to inadequate doses of solar ultraviolet-B radiation. Cancer 94:1867-1875
34. Nürnberg B, Gräber S, Gärtner B et al (2009) Reduced serum 25-Hydroxyvitamin D levels in stage IV melanoma patients. Anticancer Res 29:3669-3674
35. Newton-Bishop JA, Beswick S, Randerson-Moor J et al (2009) Serum 25-hydroxyvitamin D3 levels are associated with breslow thickness at presentation and survival from melanoma. J Clin Oncol 27(32):5439
36. Hutchinson PE, Osborne JE, Lear JT et al (2000) Vitamin D receptor polymorphisms are associated with altered prognosis in patients with malignant melanoma. Clin Cancer Res 6(2):498-504
37. Bastuji-Garin S, Diepgen TL (2002) Cutaneous malignant melanoma, sun exposure and sunscreen use: epidemiological evidence. Br J Dermatol 146 (Suppl 61):24-30
38. Reichrath J (2003) Protecting against adverse effects of sun protection? J Am Acad Dermatol 49(6):1204-1206
39. Reichrath J, Querings K (2004) Vitamin D deficiency needs to be detected and treated in solid-organ transplant recipients (OTRs). Dermatol Surg 30(12):1501-1501
40. Querings K, Reichrath J (2004) A plea for detection and treatment of vitamin D deficiency in patients under photoprotection, including patients with xeroderma pigmentosum and basal cell nevus syndrome. Cancer Cause Control 15(2):219